HackerPapers

arXiv:1903.11789cs.LG

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization

Evan N. Feinberg, Robert Sheridan, Elizabeth Joshi, Vijay S. Pande, Alan C. Cheng

Abstract

The Absorption, Distribution, Metabolism, Elimination, and Toxicity (ADMET) properties of drug candidates are estimated to account for up to 50% of all clinical trial failures. Predicting ADMET properties has therefore been of great interest to the cheminformatics and medicinal chemistry communities in recent decades. Traditional cheminformatics approaches, whether the learner is a random forest or a deep neural network, leverage fixed fingerprint feature representations of molecules. In contrast, in this paper, we learn the features most relevant to each chemical task at hand by representing each molecule explicitly as a graph, where each node is an atom and each edge is a bond. By applying graph convolutions to this explicit molecular representation, we achieve, to our knowledge, unprecedented accuracy in prediction of ADMET properties. By challenging our methodology with rigorous cross-validation procedures and prospective analyses, we show that deep featurization better enables molecular predictors to not only interpolate but also extrapolate to new regions of chemical space.

arXiv comments
41 pages
Journal reference
DOI
Subjects
cs.LGMachine Learning stat.MLMachine Learning (Statistics)

On Hacker News

Linked by 2 identifiable commenters in 14 comments across 14 threads, from Dec 2019 to Dec 2020.

Comments linking this paper, per year.

Discussed in comments14 threads

    • Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new…

      salt-lickerView on HNParent context

    • This post is nicely written. We are from the Pande Lab @ Stanford and are very supportive of this work being done by Barzilay et al at MIT. We cite each others' papers for good reason. If this type of research interests anyone here, Genesis Therapeutics -- Stanford spinout and…

      GenesisTxView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Small…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core…

      salt-lickerView on HNParent context

    • Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core…

      salt-lickerView on HNParent context

Submitted to Hacker News

Connected through shared HN threads, not inferred similarity or a recommendation.